Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 8:20 pm Purchase | 2026-03-31 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | ADAR1 Capital Management, LLC | 2,434,941 6.000% | 1,420,783![]() (+140.09%) | Filing History |
| 2026-05-15 8:16 pm Purchase | 2026-03-31 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | ADAR1 Capital Management, LLC | 102,883 4.900% | 44,653![]() (+76.68%) | Filing History |
| 2026-05-15 8:13 pm Purchase | 2026-03-31 | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | ADAR1 Capital Management, LLC | 13,860,028 9.900% | 1,167,641![]() (+9.20%) | Filing History |
| 2026-05-15 8:06 pm Purchase | 2026-03-31 | 13G | GRACE THERAPEUTICS, INC GRCE | ADAR1 Capital Management, LLC | 1,717,426 9.900% | 68,635![]() (+4.16%) | Filing History |
| 2026-05-15 8:03 pm Purchase | 2026-03-31 | 13G | LEONABIO INC LONA | ADAR1 Capital Management, LLC | 727,481 7.700% | 727,481![]() (New Position) | Filing History |
| 2026-05-15 7:59 pm Purchase | 2026-03-31 | 13G | HELIX ACQUISITION CORP. III US HLXC | ADAR1 Capital Management, LLC | 1,000,000 5.600% | 1,000,000![]() (New Position) | Filing History |
| 2026-02-17 8:17 pm Purchase | 2025-12-31 | 13G | OVID THERAPEUTICS INC OVID | ADAR1 Capital Management, LLC | 9,284,166 6.900% | 9,284,166![]() (New Position) | Filing History |
| 2026-02-17 8:16 pm Purchase | 2025-12-31 | 13G | SPRUCE BIOSCIENCES INC SPRB | ADAR1 Capital Management, LLC | 58,000 5.400% | 58,000![]() (New Position) | Filing History |
| 2026-02-17 8:15 pm Purchase | 2025-12-31 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | ADAR1 Capital Management, LLC | 1,014,158 7.900% | 1,014,158![]() (New Position) | Filing History |
| 2026-02-17 8:14 pm Purchase | 2025-12-31 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | ADAR1 Capital Management, LLC | 58,230 6.900% | 58,230![]() (New Position) | Filing History |
| 2026-02-17 8:13 pm Purchase | 2025-12-31 | 13G | ADAGIO MED INC ADGM | ADAR1 Capital Management, LLC | 1,205,447 5.700% | 1,205,447![]() (New Position) | Filing History |
| 2026-02-17 6:23 pm Sale | 2025-12-31 | 13G | BIOAGE LABS INC BIOA | ADAR1 Capital Management, LLC | 135,560 0.400% | -1,801,563![]() (-93.00%) | Filing History |
| 2026-02-17 6:22 pm Purchase | 2025-12-31 | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | ADAR1 Capital Management, LLC | 12,692,387 9.900% | 4,954,693![]() (+64.03%) | Filing History |
| 2026-02-17 6:20 pm Sale | 2025-12-31 | 13G | IBIO INC PAR $0.001 IBIO | ADAR1 Capital Management, LLC | 1,351,671 4.400% | -442,384![]() (-24.66%) | Filing History |
| 2026-02-17 6:19 pm Sale | 2025-12-31 | 13G | PERCEPTIVE CAP SOLUTIONS CORP PCSC | ADAR1 Capital Management, LLC | 456,720 5.100% | -293,280![]() (-39.10%) | Filing History |
| 2026-02-17 6:17 pm Purchase | 2025-12-31 | 13G | GRACE THERAPEUTICS, INC GRCE | ADAR1 Capital Management, LLC | 1,648,791 9.900% | 114,537![]() (+7.47%) | Filing History |
| 2025-11-14 7:47 pm Sale | 2025-09-30 | 13G | PROTHENA CORP PLC SHS PRTA | ADAR1 Capital Management, LLC | 1,469,098 2.700% | -1,905,911![]() (-56.47%) | Filing History |
| 2025-11-14 7:45 pm Purchase | 2025-09-30 | 13G | EQUILLIUM INC EQ | ADAR1 Capital Management, LLC | 6,194,882 9.900% | 6,194,882![]() (New Position) | Filing History |
| 2025-11-14 7:44 pm Purchase | 2025-09-30 | 13G | ACASTI PHARMA INC NO PAR ACST | ADAR1 Capital Management, LLC | 1,534,254 9.900% | 32,111![]() (+2.14%) | Filing History |
| 2025-10-15 06:50 am Sale | 2025-10-15 | 13D | KEROS THERAPEUTICS INC KROS | ADAR1 Capital Management, LLC | 0 0.000% | -5,389,264![]() (Position Closed) | Filing History |

